Blennow K - Search Results

1

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects.

Xu C, Sellgren CM, Fatouros-Bergman H, Piehl F, Blennow K, Zetterberg H, Brinkmalm A, Santillo AF, Lundgren S, Cervenka S, Engberg G, Erhardt S; Karolinska Schizophrenia Project (KaSP) Consortium. Xu C, et al. Among authors: blennow k. IBRO Rep. 2020 Apr 13;8:136-142. doi: 10.1016/j.ibror.2020.04.001. eCollection 2020 Jun. IBRO Rep. 2020. PMID: 32490278 Free PMC article.

2

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.

Erhardt S, Blennow K, Nordin C, Skogh E, Lindström LH, Engberg G. Erhardt S, et al. Among authors: blennow k. Neurosci Lett. 2001 Nov 2;313(1-2):96-8. doi: 10.1016/s0304-3940(01)02242-x. Neurosci Lett. 2001. PMID: 11684348

3

Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

Nilsson CL, Brinkmalm A, Minthon L, Blennow K, Ekman R. Nilsson CL, et al. Among authors: blennow k. Peptides. 2001 Dec;22(12):2105-12. doi: 10.1016/s0196-9781(01)00571-x. Peptides. 2001. PMID: 11786197

4

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

Zetterberg H, Wahlund LO, Blennow K. Zetterberg H, et al. Among authors: blennow k. Neurosci Lett. 2003 Nov 27;352(1):67-9. doi: 10.1016/j.neulet.2003.08.011. Neurosci Lett. 2003. PMID: 14615052

5

Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease.

Johansson A, Katzov H, Zetterberg H, Feuk L, Johansson B, Bogdanovic N, Andreasen N, Lenhard B, Brookes AJ, Pedersen NL, Blennow K, Prince JA. Johansson A, et al. Among authors: blennow k. Hum Genet. 2004 May;114(6):581-7. doi: 10.1007/s00439-004-1107-9. Epub 2004 Mar 18. Hum Genet. 2004. PMID: 15034781

6

APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

Prince JA, Zetterberg H, Andreasen N, Marcusson J, Blennow K. Prince JA, et al. Among authors: blennow k. Neurology. 2004 Jun 8;62(11):2116-8. doi: 10.1212/01.wnl.0000128088.08695.05. Neurology. 2004. PMID: 15184629

7

Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.

Zetterberg H, Andreasen N, Blennow K. Zetterberg H, et al. Among authors: blennow k. Neurosci Lett. 2004 Sep 2;367(2):194-6. doi: 10.1016/j.neulet.2004.06.001. Neurosci Lett. 2004. PMID: 15331151

8

Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results.

Zetterberg H, Blennow K. Zetterberg H, et al. Among authors: blennow k. Neurol Sci. 2004 Dec;25(5):301-2. doi: 10.1007/s10072-004-0358-5. Neurol Sci. 2004. PMID: 15624089 No abstract available.

9

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.

Nilsson LK, Linderholm KR, Engberg G, Paulson L, Blennow K, Lindström LH, Nordin C, Karanti A, Persson P, Erhardt S. Nilsson LK, et al. Among authors: blennow k. Schizophr Res. 2005 Dec 15;80(2-3):315-22. doi: 10.1016/j.schres.2005.07.013. Epub 2005 Aug 25. Schizophr Res. 2005. PMID: 16125901

10

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

Rüetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, McGuire J, Karlsson M, Rymo L, Davies H, Minthon L, Blennow K. Rüetschi U, et al. Among authors: blennow k. Exp Neurol. 2005 Dec;196(2):273-81. doi: 10.1016/j.expneurol.2005.08.002. Epub 2005 Sep 8. Exp Neurol. 2005. PMID: 16154129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,200 results

Search Page

Filters